Streetbeat News

AKAN

Akanda Corp.

https://www.akandacorp.com

Industry

Drug Manufacturers - Specialty & Generic

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Open

1.55

Mkt cap

2.1M

Volume

38K

High

1.58

P/E Ratio

N/A

52-wk high

56.80

Low

1.45

Div yield

N/A

52-wk low

1.22

Akanda Corp. (NASDAQ: AKAN) will implement a 1-for-2 reverse stock split effective November 14, 2024. This move was approved by shareholders and the Board of Directors earlier this year.

Portfolio Pulse from

November 12, 2024 | 1:45 pm

A legislative committee in Ireland has recommended the limited legalization of marijuana and the decriminalization of all illicit drugs for personal use. The report emphasizes a health-led approach to drug policy, aiming to reduce harm and stigma. The committee suggests studying regulated cannabis markets in other countries and expanding Ireland's medical marijuana program.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 7:26 pm

Several health care stocks experienced significant price movements in Monday's pre-market session. GRI Bio, BioVie, LogicMark, VSee Health, Molecular Partners, and Windtree Therapeutics saw notable gains, while Gritstone Bio, Mobile-health Network, LifeStance Health, Akanda, Phio Pharma, and Burning Rock Biotech experienced declines.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 12:08 pm

Several health care stocks experienced significant price movements in Monday's pre-market session. GRI Bio, BioVie, LogicMark, VSee Health, Molecular Partners, and Windtree Therapeutics saw notable gains, while Gritstone Bio, Mobile-health Network, LifeStance Health, Akanda, Phio Pharma, and Burning Rock Biotech experienced declines.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 12:07 pm

In Friday's pre-market session, several health care stocks experienced significant price movements. Notable gainers included Catheter Precision (AMEX:VTAK) with a 151.9% increase, Akanda (NASDAQ:AKAN) up 71.13%, and Tenon Medical (NASDAQ:TNON) rising 39.06%. On the losing side, Orgenesis (NASDAQ:ORGS) fell 37.9%, Molecular Templates (NASDAQ:MTEM) dropped 30.11%, and NKGen Biotech (NASDAQ:NKGN) decreased by 29.02%.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 12:09 pm

Intuitive Surgical shares rose 6.9% in pre-market trading due to better-than-expected Q3 results and regulatory clearance in South Korea. Netflix also gained 5.8% after strong Q3 results. Several other stocks experienced significant pre-market movements.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 10:52 am

In Thursday's after-market session, several health care stocks experienced significant price movements. Notable gainers included Catheter Precision (VTAK) with a 71.1% increase, Tenon Medical (TNON) up 51.31%, and Akanda (AKAN) rising 38.14%. On the losing side, NKGen Biotech (NKGN) fell 35.0%, Molecular Templates (MTEM) dropped 12.95%, and Travere Therapeutics (TVTX) decreased by 11.03%.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 8:30 pm

In Friday's after-market session, several health care stocks experienced significant price movements. Notable gainers included Tevogen Bio Holdings, Allakos, and Unicycive Therapeutics, while Akanda, Dogwood Therapeutics, and Nexalin Technology were among the losers.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:31 pm

In Friday's pre-market session, several healthcare stocks experienced significant movements. Notable gainers included NewGenIvf Group (NIVF) with a 71.8% increase, Conduit Pharmaceuticals (CDT) up by 40.77%, and Kindly MD (KDLY) rising by 17.76%. On the losing side, Carmell (CTCX) fell by 12.4%, Jin Medical International (ZJYL) decreased by 8.74%, and LakeShore Biopharma (LSB) dropped by 8.14%.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:07 pm

Aehr Test Systems shares surged 14% in pre-market trading after reporting better-than-expected Q1 earnings and revenue. Several other stocks, including NewGenIvf Group and ZenaTech, also saw significant pre-market movements.

Portfolio Pulse from Avi Kapoor

October 11, 2024 | 10:20 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.